significant changes Q3-2017 Q4-2016 Q3-2017 VS Q4-2016 (MB) (MB) % Cash and cash equivalent 1,258.8 1,873.9 (615.1) (32.8)% Current Investment – Trading Securities - 25.2 (25.2) (100.0)% Trade and Other
December 2017 After You Public Company Limited (the “Company”) operates dessert and bakery businesses. The Company divided its businesses into 2 categories, including 1) Dessert café under the trademark name
to generate additional income. 2018 is the Year of Change as all aspects of the operation are modified in order for the Company to achieve sustainable growth under sufficiency economy principles. The
performance in the consolidated financial statements for the nine-month of 2019, the Company reported a net profit of 380.0 million Baht, equivalent to a net profit margin of 4.70 percent. The details were as
Limited (“TSEO”) which is a subsidiary with 100% shareholding by Thai Solar Energy Public Company Limited equivalent to 74,000,000 ordinary shares at the par value of Baht 10 per share, totaling transaction
Experience under which there will be the increase in the registered capital of Hero Experience, equivalent to 30 percent of the registered capital of Hero Experience, at the price per share of up to Baht
ordinary shares of 1,437,456,000 shares under IPO with a par value of THB 5.00 per share and IPO price at THB 5.20 per share. Nevertheless, the Company intends to maintain its shareholding in SHR at 60% of
million or 2% from Q1/2020 • However, EBITDA margin in Q1/2021 was 31.5%, increased by 5.1% from Q1/2020 as a result of the effective control of selling and administrative expenses under the implementation
detailed under “Details of UE Group Companies” in 3.1 of the Information Memorandum on the Asset Acquisition and Connected Transactions of U City Public Company Limited (Enclosure 1)), (b) rights in the loan
, MahaSamutr Villa and MahaSamutr Country Club, as well as the food and beverage business under the "DEAN & DELUCA" brand. After the purchase of PP1 and PP3’s share in the proportion of 49. 00 percent and 48. 72